Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SERA | US
-0.05
-2.50%
Healthcare
Diagnostics & Research
30/06/2024
06/03/2026
1.95
1.96
2.02
1.90
Sera Prognostics Inc. a women's health diagnostic company discovers develops and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions including preeclampsia molecular time-to-birth gestational diabetes mellitus fetal growth restriction stillbirth and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City Utah.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
43.9%1 month
69.5%3 months
69.8%6 months
71.0%-
-
4.28
0.02
0.02
-0.61
1.93K
-
-34.53M
65.07M
65.07M
-
-38.55K
-
-80.50
-44.77
8.09
3.45
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.86
Range1M
0.92
Range3M
1.95
Rel. volume
1.07
Price X volume
57.48K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Co-Diagnostics Inc | CODX | Diagnostics & Research | 2.11 | 67.33M | -9.44% | n/a | 3.57% |
| ENDRA Life Sciences Inc | NDRA | Diagnostics & Research | 3.36 | 61.79M | -2.04% | n/a | 3.13% |
| Cytosorbents Corporation | CTSO | Diagnostics & Research | 0.798 | 43.43M | -0.88% | n/a | 159.92% |
| Neuronetics Inc | STIM | Diagnostics & Research | 1.38 | 41.82M | -2.13% | n/a | 323.03% |
| Precipio Inc | PRPO | Diagnostics & Research | 26.5342 | 39.33M | 0.05% | n/a | 9.66% |
| BioTelemetry Inc | BEAT | Diagnostics & Research | 1.4 | 37.19M | 0.00% | n/a | 0.00% |
| STAR EQUITY HOLDINGS INC | STRR | Diagnostics & Research | 10.07 | 32.44M | 0.20% | n/a | 26.85% |
| Biomerica Inc | BMRA | Diagnostics & Research | 1.92 | 32.30M | -2.54% | n/a | 13.22% |
| MYnd Analytics Inc | MYND | Diagnostics & Research | 0.4269 | 19.49M | 1.62% | n/a | 117.50% |
| VolitionRx Limited | VNRX | Diagnostics & Research | 0.1981 | 18.25M | 0.66% | n/a | -26.88% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ILAG | ILAG | Building Products & Equipment | 2.4783 | 44.76M | 6.82% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.21 | 32.29M | -3.49% | 0.03 | 16.03% |
| Reading International Inc | RDI | Media - Diversified | 0.9993 | 28.21M | -2.98% | n/a | 4054.78% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.6345 | 12.26M | -10.63% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.4799 | 3.78M | -0.68% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.397 | 3.78M | -1.73% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.39 | 1.32M | -3.24% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.61 | - | Cheaper |
| Ent. to Revenue | 1,928.54 | - | Expensive |
| PE Ratio | - | 40.09 | - |
| Price to Book | 4.28 | 77.50 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 69.83 | - | Par |
| Debt to Equity | 0.02 | -14.36 | Expensive |
| Debt to Assets | 0.02 | 0.34 | Cheaper |
| Market Cap | 65.07M | - | Emerging |